InvestorsHub Logo
Followers 446
Posts 54534
Boards Moderated 7
Alias Born 02/15/2011

Re: None

Friday, 04/29/2016 3:52:41 PM

Friday, April 29, 2016 3:52:41 PM

Post# of 130502
400% MORE Dilution COMING



http://ih.advfn.com/p.php?pid=nmona&article=69614670

Quote:On December 7, 2015, Amarantus Bioscience Holdings, Inc. (the “Company”) held a Special Meeting of Stockholders (the “Special Meeting”). An aggregate of 10,091,744.46 shares held by holders of the Company’s voting stock , constituting a quorum, were represented in person or by valid proxies at the Annual Meeting. The final results for each of the matters submitted to a vote of stockholders at the Annual Meeting, as set forth in the Definitive Proxy Statement, filed with the Securities and Exchange Commission on November 4, 2015, as supplemented, are as follows:

Proposal 1. The adoption of an amendment to the Company’s Articles of Incorporation to increase the authorized number of shares of common stock to 150,000,000 from 35,000,000 was ratified and approved by the stockholders by the votes set forth in the table below:

For Against Abstain Broker Non Vote
8,557,177.46 /// 1,502,348 /// 32,219 /// 0

Proposal 2. The adoption of an amendment to the Company’s 2014 Stock Plan to increase the number of shares of common stock authorized for issuance thereunder from 1,025,868 to 7,500,000 was ratified and approved by the stockholders by the votes set forth in the table below:

For Against Abstain Broker Non Vote
4,990,876.46 /// 967,182 /// 78,399 /// 0